510(k) K023089
K023089 is an FDA 510(k) premarket notification submitted by Biocure, Inc. for the device "GELSPHERES EMBOLIC AGENT". The FDA issued a decision of Substantially Equivalent on Dec 16, 2002. The device falls under product code HCG (Device, Neurovascular Embolization), a Class II device regulated under 21 CFR 882.5950. Biocure, Inc. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 16, 2002
- Date Received
- Sep 17, 2002
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Device, Neurovascular Embolization
- Device Class
- Class II
- Regulation Number
- 882.5950
- Review Panel
- NE
- Submission Type
- 510(k)
Need the full FDA record for Biocure, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.